A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

Lee Schwartzberg; Timothy Rearden; Lorrin Yee; Barry Mirtsching; Veena Charu; Hung Lam; Tom Lillie; Ronald Burkes; Peter Silberstein

A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

Lee Schwartzberg, Timothy Rearden, Lorrin Yee, Barry Mirtsching, Veena Charu, Hung Lam, Tom Lillie, Ronald Burkes, Peter Silberstein

Department of Medicine

Research output: Contribution to journal › Article

1 Scopus citations

Original language	English (US)
Pages (from-to)	22-23
Number of pages	2
Journal	Journal of Supportive Oncology
Volume	5
Issue number	4 SUPPL. 2
State	Published - Apr 1 2007

All Science Journal Classification (ASJC) codes

Oncology
Pharmacology (medical)

Access to Document

Cite this

Schwartzberg, L., Rearden, T., Yee, L., Mirtsching, B., Charu, V., Lam, H., Lillie, T., Burkes, R., & Silberstein, P. (2007). A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia. Journal of Supportive Oncology, 5(4 SUPPL. 2), 22-23.

A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia. / Schwartzberg, Lee; Rearden, Timothy; Yee, Lorrin; Mirtsching, Barry; Charu, Veena; Lam, Hung; Lillie, Tom; Burkes, Ronald; Silberstein, Peter.

In: Journal of Supportive Oncology, Vol. 5, No. 4 SUPPL. 2, 01.04.2007, p. 22-23.

Research output: Contribution to journal › Article

Schwartzberg, Lee ; Rearden, Timothy ; Yee, Lorrin ; Mirtsching, Barry ; Charu, Veena ; Lam, Hung ; Lillie, Tom ; Burkes, Ronald ; Silberstein, Peter. / A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia. In: Journal of Supportive Oncology. 2007 ; Vol. 5, No. 4 SUPPL. 2. pp. 22-23.

@article{0e645455cbb641fca12309c544def909,

title = "A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia",

author = "Lee Schwartzberg and Timothy Rearden and Lorrin Yee and Barry Mirtsching and Veena Charu and Hung Lam and Tom Lillie and Ronald Burkes and Peter Silberstein",

year = "2007",

month = apr,

day = "1",

language = "English (US)",

volume = "5",

pages = "22--23",

journal = "Journal of Supportive Oncology",

issn = "1544-6794",

publisher = "Biolink Communications, Inc.",

number = "4 SUPPL. 2",

}

TY - JOUR

T1 - A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

AU - Schwartzberg, Lee

AU - Rearden, Timothy

AU - Yee, Lorrin

AU - Mirtsching, Barry

AU - Charu, Veena

AU - Lam, Hung

AU - Lillie, Tom

AU - Burkes, Ronald

AU - Silberstein, Peter

PY - 2007/4/1

Y1 - 2007/4/1

UR - http://www.scopus.com/inward/record.url?scp=34250615108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250615108&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:34250615108

VL - 5

SP - 22

EP - 23

JO - Journal of Supportive Oncology

JF - Journal of Supportive Oncology

SN - 1544-6794

IS - 4 SUPPL. 2

ER -